Pablo J. Cagnoni, Director at CRISPR Therapeutics AG (CRSP), sold 7,500 shares at $52.00 ($390K) on 2019-10-30, disclosed to the SEC on 2019-11-01.
Open-market sale of $390k CRSP by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| INCY | SELL | 2026-08-14 | $1.3M | — | Filing → |
| INCY | SELL | 2026-08-07 | $1.3M | — | Filing → |
| INCY | SELL | 2026-08-04 | $1.9M | — | Filing → |